-
1
A 487-gene expression profile test was developed for atopic dermatitis.
-
2
The study identifies JAK inhibitor responders vs. Th2 biologic responders.
-
3
Noninvasive skin sampling was used for testing.
-
4
Higher clearance and symptom control were seen in JAK responders.
-
5
The assay aids in therapy selection tailored to molecular profiles.
-
6
Only patients aged 12+ were validated in the study.
-
7
Aim to enhance patient outcomes and streamline systemic therapy.
Original Source(s)
Gene Test Guides Eczema Care
Skin scraping assay may help labs support targeted systemic treatment in atopic dermatitis
March 2, 2026
-
3 min
Related Content
First Death From Alaskapox Reported
Alaska health officials warned of the risk of Alaskapox in the wake of the first death from the disease in January 2024.
April 29, 2024
-
2 min
Higher H. pylori Prevalence Seen in Severe Psoriasis
Psoriasis patients show higher Helicobacter pylori infection rates, with potential implications for further research into disease associations.
January 10, 2025
-
2 min
Physician Turnover After Private Equity Exits
Researchers found physicians in private equity-exiting practices were less likely to stay and more likely to join larger groups within 2 years.
February 17, 2025
-
3 min